Practicability and Acceptability of Stylomax® in Children
NCT00476385
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Growth Hormone Deficiency
Interventions
DRUG:
somatropine
Sponsor
Sanofi